Our analysis as described in this research letter highlights the fact
that age outweighs many other factors in people with T2DM in relation to
mortality from SARS-CoV-2 virus, once infected. This fact should be
taken into account in relation to the vaccination programme against
coronavirus-19 in people with T2DM in the UK and elsewhere.